Skip to main content

2023 ACCP Annual Meeting Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Title

Browse by Poster Title

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#

T
077
TABLET: Relative Bioavailability & Bioequivalence Study of Niraparib Tablets & Capsules in Patients With Advanced Solid Tumors

Favorite
177
The Effect of a High-Fat Meal on the Pharmacokinetics of Dordaviprone in Healthy Adult Participants

Favorite
063
The Effect of Administering Dordaviprone as Capsule Contents Mixed With Applesauce or Dissolved in Gatorade on the Pharmacokinetics of Dordaviprone in Healthy Adult Participants

Favorite
166
The Effect of Food & the Proton Pump Inhibitor (PPI) Esomeprazole on the Single-Dose Pharmacokinetics (PK) & Safety of ARV-766, a PROteolysis Targeting Chimera (PROTAC) Androgen Receptor (AR) Degrader, in Healthy Volunteers

Favorite
163
The Effect of Food & the Proton Pump Inhibitor (PPI) Esomeprazole on the Single-Dose Pharmacokinetics (PK) and Safety of the PROteolysis Targeting Chimera (PROTAC) Androgen Receptor (AR) Degrader Bavdegalutamide in Healthy Volunteers

Favorite
074
The Effect of Itraconazole, a Strong CYP3A4 Inhibitor, on the Pharmacokinetics of Dordaviprone in Healthy Adult Participants

Favorite
169
The Effect of Rabeprazole, a Proton-Pump Inhibitor, on the Pharmacokinetics of Dordaviprone in Healthy Adult Participants

Favorite
062
The MILK Study: Investigating Pharmacokinetics of Low-calorie Sweeteners in Mother Infant Dyads

Favorite
044
The Role of Exposure-Response Analyses in Determination of Recommended Dose for Expansion in a Phase I/Ib Study of NIZ985 Alone & in Combination With Spartalizumab in Cancer Patients

Favorite
089
The Utilization of Pharmacokinetic/Pharmacodynamic (PK/PD) Model-based Analysis of Myelosuppression in Clinical Trials: Analysis from Adavosertib Clinical Studies

Favorite